RA/FTP has two exclusive contracts with generic naloxone manufacturers who sell naloxone to us at an extremely discounted price. We purchase the naloxone directly from the companies with our Medical Director’s authority and store it securely at our warehouse.

Until the FDA removes the unnecessary and barrier-causing Rx designation on naloxone, this safe and life-saving “pure antidote” to opioid overdose (which is not a controlled substance or scheduled drug) can only be purchased directly from a pharmaceutical company with a prescriber’s license on file. Naloxone inhabits a unique place in terms of over-the-counter and prescription drugs—it is not quite either, and there is not yet a category for a drug like it. State and local laws and federal declarations have attempted to go as far as they can to de-regulate naloxone with special regulatory carve-outs and exceptions, short of removing the Rx. Standing orders issued by states, health departments and pharmacies seek to remove the patient-doctor relationship required to dispense a rx drug in the US, rendering the drug de-facto “non-prescription” without actually removing the Rx. Because of this confusing network of laws and regulations that differ state by state, naloxone access remains difficult and prone to real and perceived barriers.

RA/FTP is creating the opportunity for under-resourced programs to truly scale up their distribution of naloxone to save lives by accessing affordable and donated naloxone. 

RA/FTP legally purchases naloxone from two different manufacturers under the authority and license of our Medical Director. The naloxone is then inventoried and stored in our secure location. When a program requests membership to RA/FTP to purchase or receive donated naloxone from us, we review whether or not the program can receive and distribute naloxone according to their own state and local regulations around naloxone procurement and distribution. If it is not authorized for harm reduction programs to acquire or distribute their own naloxone in a given state, we will follow-up with that program to provide them with technical and legal assistance.

No. RA/FTP is a non-profit organization (501c3 pending) that is supported by grants, donations and self-sustaining revenue generated by the sale of naloxone to funded programs. All revenue generated by the sale of naloxone at our modest, tiered price increases (over cost to us) is used to support the infrastructure of RA/FTP, cover shipping and handling, and to acquire a supply of naloxone for donation to under-resourced harm reduction programs.

Not yet. We are hoping to work directly with generic manufacturers of nasal naloxone in the future as those products become available, in order to offer an affordable nasal product to harm reduction programs.

The majority of our programs are providing syringe access and harm reduction services directly to people who use drugs. They also provide access to naloxone for people at high risk of overdose at treatment programs, jails and prisons, or through mail order services.

2019 was the first year that our programs ordered and distributed over 1 million doses of naloxone. In 2020, during the height of the COVID19 pandemic, that number increased to 1.3 million doses. In the first quarter of 2021 before the Pfizer naloxone shortage disrupted access in April, our programs had already ordered 250,000 doses of naloxone. From 2017 through the first quarter of 2021, our programs purchased 3,948,860 naloxone doses.

We sure can! Schedule a consultation with us (always free for harm reduction programs) and we can help you navigate the barriers you face.

Yes! Fill out an application and we'll contact you to discuss pricing. 

Fill out our application and, once you’re approved, you’ll get access to our shop!

Reach out to info@remedyallianceftp.org and we’ll get back to you. 

Reach out to info@remedyallianeftp.org and we’ll get back to you